Amphastar Pharmaceuticals
AMPH
AMPH
119 hedge funds and large institutions have $474M invested in Amphastar Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 42 increasing their positions, 49 reducing their positions, and 23 closing their positions.
Holders
119
Holders Change
-15
Holders Change %
-11.19%
% of All Funds
2.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
42
Reduced
49
Closed
23
Calls
$32K
Puts
$372K
Net Calls
-$340K
Net Calls Change
+$137K
Top Buyers
1 |
1
Invesco
Atlanta,
Georgia
|
$21.2M |
2 |
EAM
2
Eagle Asset Management
St Petersburg,
Florida
|
$5.48M |
3 |
3
Goldman Sachs
New York
|
$8.32M |
4 |
4
BlackRock
New York
|
$118M |
5 |
5
Renaissance Technologies
New York
|
$16.1M |